Center for Digestive System Diseases

The Centre for Digestive Diseases (CDD) is a world-renowned medical institution and biotech entity specializing in the research and treatment of gastrointestinal disorders through innovative microbial therapies. Founded by Professor Thomas Borody, the center is a pioneer in the development of Fecal Microbiota Transplantation (FMT) and was instrumental in the development of 'Triple Therapy' for Helicobacter pylori. CDD focuses on the 'gut microbiome' as a therapeutic target for a wide range of conditions, including inflammatory bowel disease, chronic infections, and even neurological disorders linked to gut health. The center operates as both a clinical facility providing specialized care and a research hub developing novel biotherapeutic protocols.